Abstract: The embodiment of the present application discloses a 3D interaction method, device, computer equipment and storage medium. The method comprises the steps of acquiring motion trail data of a gesture; identifying hand joint position information of the gesture based on the motion trail data; identifying a trigger as a corresponding trigger gesture to realize an interaction operation in an interactive interface based on stay or movement of the hand joint position information within a preset time, wherein the gesture is within an acquisition scope of non-contact gesture control equipment. Thus, the usability of non-contact gesture recognition is improved and the misjudgment rate is reduced with higher operational fluency, better compatibility and improved user experience.

Abstract: The embodiment of the present application discloses a method, device, system and storage medium for displaying a holographic portrait in real time, applicable to reducing latency and achieving real-time display. A method in the application embodiment comprises: acquiring portrait data of a figure through somatosensory equipment; acquiring portrait data within a preset range as effective portrait data; blurring and storing the effective portrait data; sending the blurred effective portrait data to holographic display equipment frame by frame based on a first-in first-out principle, so as to display the effective portrait data of the figure on holographic projection of the holographic display equipment in real time, achieve real-time display of the holographic portrait, have a lower latency and improve user experience.

Abstract: A flexible conductive diaphragm comprises at least one conductive film, and the conductive film comprises a flexible support layer (1), a flexible sensitive layer (2) overlapped on the flexible support layer (1), a flexible conductive layer (3) overlapped on the flexible sensitive layer (2), and an electrode (4) electrically connected with the flexible conductive layer (3). A method for preparing the flexible conductive diaphragm and a flexible vibration sensor based on the flexible conductive diaphragm are provided. With the combination of the techniques such as the flexible material, the nano-material and the arrayed micro-structure, the flexible vibration sensor has the characteristics of high sensitivity, low preparation cost, light weight, small thickness, small size, and being foldable and flexible, and can be applied in wearable or adherable electronic devices.

Abstract: The present invention discloses a method for the preparation of skipjack tuna extract having hypouricemic effect and the use thereof, which is simple in processing operations, low in production cost, and is free from pollution. The prepared skipjack tuna extract has a potent hypouricemic effect, and has a significant therapeutic effect on hyperuricemia, with no toxic and side effects. The method in an example of the present invention comprises: pretreating skipjack tuna to obtain a skipjack tuna slurry; enzymolysing the skipjack tuna slurry to obtain a crude enzymolysis liquid; removing fishy smell and bitter taste, removing impurities by activated charcoal, and filtering to obtain a refinded enzymolysis liquid; concentrating under vacuum and spray-drying to obtain the skipjack tuna extract. The present invention further discloses use of the skipjack tuna extract in health care products or food products.

Abstract: A computer-implemented method includes receiving a data stream, the data stream including one or more driving factors. The computer-implemented method further includes comparing the one or more driving factors to one or more known driving factors to identify a driving scenario. The computer-implemented method further includes monitoring the driving scenario for a risk. Monitoring the driving scenario for a risk further includes detecting the risk. The computer-implemented method further includes generating an intervention, wherein the intervention is generated based on detecting the risk for the driving scenario. A corresponding computer system and computer program product are also disclosed.

Abstract: Systems and methods are described herein for analyzing the performance of a communications network (e.g., a mobile telecommunications network) using customer-centric and/or subscriber-centric data and information. In some embodiments, the systems and method may determine key performance indicators for a communications network by accessing call detail records from multiple communications network sources, generating a database of one or more customer stats table (CSTs) based on the accessed call records, wherein the CSTs include records for each individual customers of the communications network, and determining one or more key performance indicators (KPIs) for the overall network based on the records stored by the one or more customer stats tables.

Abstract: Disclosed are compounds of Formula A-1, or a salt thereof: Formula A-1, where J, K, Q and R1 are as defined herein, which compounds have properties for inhibiting sodium ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A-1 or their salts, and methods of treating pain (e.g. chronic pain), or cough or itch disorders using the same.

Abstract: Disclosed are compounds of Formula A, or a salt thereof: wherein R1, R2, and E are defined herein, which compounds have properties for inhibiting Nav 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A or their salts, and methods of treating pain disorders, cough, and itch using the same.

Abstract: Disclosed is a method of inhibiting growth of a melanoma cancer cell. The method includes contacting the melanoma cancer cell with an effective amount of a composition and the composition contains polymethoxyflavone. The polymethoxyflavone can be applied in an amount of 0.1 ?mol/L-1000 ?mol/L. A method of treating a subject having melanoma with the above discussed composition is also included.

Abstract: Provided is a papillomavirus chimeric protein, the skeleton thereof being a papillomavirus L1 protein or a mutant thereof, at least one human papillomavirus 33-type L2 protein or mutant polypeptide thereof being embedded on the skeleton. The present papillomavirus chimeric protein can be used for preparing a vaccine for preventing papillomavirus infections and infection induced disease.

Abstract: The present invention provides a compound of Formula I, and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing unstable angina, refractory angina, myocardial infarction, transient ischemic attacks, atrial fibrillation, thrombotic stroke, embolic stroke, deep vein thrombosis, disseminated intravascular coagulation, ocular build up of fibrin, and reocclusion or restenosis of recanalized vessels. The compounds are selective Factor IXa inhibitors.

Abstract: Disclosed are compounds of Formula A, or a salt thereof, where Q, X, R1 and R2 are as defined herein, which compounds have properties for inhibiting Na 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A or their salts, and methods of treating pain (acute, post-operative, neuropathic), or cough or itch disorders using the same.

Abstract: An embodiment of the present invention discloses a travel assisting method, including: extracting trip information from content saved in a terminal and saving the extracted trip information in a trip list; selecting the trip information from the trip list, automatically connecting to a preset network address or a preset server address, and searching by using part or all of content of each piece of the selected trip information as a key word, so as to obtain assisting information corresponding to the trip information; and generating prompting information. Correspondingly, an embodiment of the present invention further discloses a terminal. The present invention enables the terminal to automatically provide effective reference information for a user according to a trip of the user, solving the problem that an operation is troublesome and time-consuming when the user obtains trip-related assisting information by using the terminal.

Abstract: The present invention relates to a compound of formula I, a stereoisomer, a prodrug, a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable solvate thereof, and a process for preparing the same, a pharmaceutical composition comprising the same, and use of the compound in the preparation of medicine preventing and treating tumors, wherein the substituents are as defined in the specification.

Abstract: The invention discloses a terminal backup and recovery method. When in backup, a user interface is provided at a terminal side first, so as to provide, according to a preset display policy, different backup categories for a user to select, wherein the different backup categories comprise different backup objects. Then, according to a backup category and object selected by the user, at the terminal side, a terminal file corresponding to the backup object is backed up at a cloud server according to a preset backup policy. When in recovery, according to a recovery category and object selected by the user, a file already backed up by the terminal/user and corresponding to the backup object is determined at the cloud server, and according to a preset recovery policy, corresponding recovery is executed at the terminal side by using the backed-up file. The invention provides classified backup and recovery, and increases the speed of backup and recovery.

Abstract: Methods for treating various cancers by administering one or more compounds that target the dimeric protein survivin are disclosed. Pharmaceutical compositions containing such compounds are also disclosed, along with general methods of identifying anti-cancer compounds that target oncogenic dimeric proteins. Exemplary compounds that can be used in the disclosed methods of treatment and pharmaceutical compositions have the chemical structure.

Abstract: Systems and methods are described herein for analyzing the performance of a communications network (e.g., a mobile telecommunications network) using customer-centric and/or subscriber-centric data and information. In some embodiments, the systems and method may determine key performance indicators for a communications network by accessing call detail records from multiple communications network sources, generating a database of one or more customer stats table (CSTs) based on the accessed call records, wherein the CSTs include records for each individual customers of the communications network, and determining one or more key performance indicators (KPIs) for the overall network based on the records stored by the one or more customer stats tables.

Abstract: Systems and methods are described herein for determining dropped call rates (DCR) for various communications networks, such as IP Multimedia Networks (IMS), which include Voice over LTE (VoLTE) networks. For example, the systems and methods utilize data (e.g. abnormal cause codes) generated by layers of the IMS networks, such as a Session Initiation Protocol (SIP) layer of the IMS network, when determining dropped call rates for IMS networks.

Abstract: Systems and methods are described herein for analyzing the performance of a communications network (e.g., a mobile telecommunications network) using customer-centric and/or subscriber-centric data and information. In some embodiments, the systems and method may determine key performance indicators for a communications network by accessing call detail records from multiple communications network sources, generating a database of one or more customer stats table (CSTs) based on the accessed call records, wherein the CSTs include records for each individual customers of the communications network, and determining one or more key performance indicators (KPIs) for the overall network based on the records stored by the one or more customer stats tables.